VIRO — ViroGates A/S Share News
0.000.00%
Last trade - 00:00- DKK69.61m
- DKK55.91m
- DKK5.31m
Brief: ViroGates H1 Operating Profit DKK -3.9 Million
Brief: Virogates Raises FY Rev Guidance
Denmark's ViroGates Q1 revenue rises 8%, net loss narrows
Brief: ViroGates Q1 Operating Profit DKK -2.9 Million
Brief: ViroGates Submits De Novo Application To U.S. FDA For suPARnostic TurbiLatex
Brief: ViroGates Reports 2025 Revenue At DKK 5.31 Million
Brief: Virogates Expects 2026 EBIT Loss Of DKK 10 Mln-12 Mln
Brief: Virogates Announces Directed Issue Raising About DKK 19.3 Mln
Brief: Supar Remedy Announces Outcome Of Tender Offer To Virogates Shareholders
Brief: ViroGates 9M Operating Profit DKK -7.9 Million
Brief: Virogates Considers Potential Equity / Capital Raise
Brief: Virogates Receives FDA Feedback On 513(G) Request
Brief: suPAR Remedy Announces Public Tender Offer To Shareholders Of Virogates At 40% Premium
Brief: Virogates Expects FY 2025 Revenue Between DKK 5 To 7 Mln
Brief: ViroGates Q1 Operating Profit DKK -2.753 Million
Brief: ViroGates FY Net Income DKK -14.345 Million
Brief: Virogates Expects 2025 Revenue In Range Of DKK 5-7 Mln
Brief: ViroGates Plans Reorganisation, Adjusts 2024 Guidance
Brief: Virogates Maintains FY 2024 Guidance